EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

DEVELOPMENT AND CHARACTERIZATION OF ORAL DISINTEGRATING TABLETS OF SITAGLIPTIN

Raghavendra Kumar Gunda, Dr J.N. Suresh Kumar

Journal of Applied Pharmaceutical Sciences and Research · 15.04.2026 · 9 (1) · 34-38

DOI: 10.31069/japsr.v9i1.04 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Pharmaceutical Sciences and Research, online erschienen am 15.04.2026. Verfasst von Raghavendra Kumar Gunda und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The current study's objective is to develop and evaluate oral disintegrating tablets (ODT) for Sitagliptin. Sitagliptin, a selective DPP-4 Inhibitor. Once DPP-4 mediated incretins are inactivated effects the glucose regulation in body. It is necessary to develop oral disintegrating tablet addressing specific need for convenience and enhanced drug delivery, helpful for diabetic patients with fast-paced life style.

Methods

Using various quantities of Croscaramellose sodium & Sodium starch glycolate as Superdisintegrants, ODT formulations of Sitagliptin were prepared utilizing the Direct Compression technique. Nine trials were developed and assessed for Pharmaceutical Product Performance.

Results

Findings indicate that all formulations meet the acceptance criteria, and kinetic modelling was applied to the In-Vitro dissolution profiles.

Conclusion

The formulation F8, which is considered as best formulation, contained 5 mg of Croscaramellose sodium and 7.5 mg of Sodium starch glycolate. Formulation (F8) follow first order (r=0.999), whereas release mechanism found to be non-fickian type (n= 0.540).

Zitieren

APA

Gunda, R. K., & Kumar, D. J. S. (2026). DEVELOPMENT AND CHARACTERIZATION OF ORAL DISINTEGRATING TABLETS OF SITAGLIPTIN. Journal of Applied Pharmaceutical Sciences and Research, 9(1), 34-38. https://doi.org/10.31069/japsr.v9i1.04

Vancouver

Gunda RK, Kumar DJS. DEVELOPMENT AND CHARACTERIZATION OF ORAL DISINTEGRATING TABLETS OF SITAGLIPTIN. Journal of Applied Pharmaceutical Sciences and Research. 2026;9(1):34-38. doi:10.31069/japsr.v9i1.04

BibTeX
@article{Gunda2026,
  author = {Gunda, Raghavendra Kumar and Kumar, Dr J.N. Suresh},
  title = {DEVELOPMENT AND CHARACTERIZATION OF ORAL DISINTEGRATING TABLETS OF SITAGLIPTIN},
  journal = {Journal of Applied Pharmaceutical Sciences and Research},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {34--38},
  doi = {10.31069/japsr.v9i1.04}
}
Kostenlos starten →